Saturday, February 9, 2013
Pharmacy Design Project Out To Bid for New Hospital Pharmacy in New York State
Pharmacy design architect Bernstein & Associates, Architects (http://bernarch.com/Healthcare-Design-Pharmacy/) is pleased to announce that a new hospital pharmacy, designed for a major teaching hospital, is now out to bid.
Pharmacy design services included: pharmacy planning, pharmacy design, pharmacy equipment planning, architectural and engineering services for the new pharmacy, pharmacy construction bidding, and pharmacy construction.
The pharmacy design project is for a complete new hospital pharmacy. The project includes all new: receiving, dispensing and compounding suite. Compounding suite includes: USP 797 compliant anteroom, new USP 797 compliant hazardous compounding room, and new USP 797 compliant non-hazardous compounding room.
About Bernstein & Associates, Architects (www.bernarch.com):
Bernstein & Associates, Architects has specialized in healthcare and lab design and construction since the firm's founding in 1990. This architecture firm is well-known for pharmacy planning, pharmacy design and pharmacy construction, including USP 797 compliant pharmacy design and construction. The firm's principal --- William N. Bernstein, AIA --- is a well-known architect of pharmacies. He has written extensively on pharmacy design and construction including USP 797 compliant pharmacies. Mr. Bernstein's USP 797 articles can be found on the USP 797 website www.usp797.org, and his pharmacy design articles can be found on the pharmacy design website www.pharmacydesign.org.
For more information about pharmacy design and pharmacy construction, contact Bernstein & Associates, Architects at:
New York (Headquarters)
Bernstein & Associates, Architects
1201 Broadway - #803, New York, NY 10001
T: 212-463-8200
F: 888-214-0670
www.bernarch.com
Also in Hartford, Princeton and Los Angeles
EMLab P&K’s Risk Assessment Pathogen Program
Dr. Joseph Manfrida from EMLab P&K’s Risk Assessment Pathogen Program begins collaboration with TestAmerica’s Ask the Expert webinar series
Dr. Joseph Manfrida has begun working with the TestAmerica Ask the Expert webinar series to bring additional opportunities for education to interested professionals. Originally known for his acclaimed presentations in bacteriology, nosocomial mycoses, and USP <797>, Dr. Manfrida is now presenting alongside the scientists of TestAmerica to create opportunities to discuss additional topics.
The Science and Ambiguity of Asbestos, will be presented on October 25th, 2012. The nature of asbestos, the threat it poses to human health, and the technologies available to investigate its presence are frequently misunderstood. Dr. Manfrida will be discussing the science behind asbestos contamination and how it interacts with the medical, legal, and technical aspects of detecting and removing the contaminate. Webinar attendees will leave with a greater understanding of the motivation and reasoning behind current practices regarding asbestos.
Course topics include:
• The controversy surrounding the definition of asbestos as well as give the current operative definition delineated by NIOSH
• Identifying the major types of asbestos
• Major medical conditions resulting from asbestos exposure and current hypotheses regarding how pathologies develop
• Current federal regulations applying to asbestos, including recommended exposure limits
• Technologies for asbestos testing
• Future goals of NIOSH asbestos research and regulation
Register at: http://www.testamericainc.com/services/webinar_series.aspx
Dr. Manfrida will discuss USP <797> on August 2nd, 2012. This USP <797> training course provides information regarding the background and purpose of USP <797> and will discuss designing and executing a USP <797> sampling regimen.
USP <797> course topics include:
• History and background of USP <797>
• Where USP <797> regulation applies
• Determining what types of testing are needed
• Designing a testing regimen
• Interpreting data
• Investigation and remediation of contamination *****************Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
The Science and Ambiguity of Asbestos, will be presented on October 25th, 2012. The nature of asbestos, the threat it poses to human health, and the technologies available to investigate its presence are frequently misunderstood. Dr. Manfrida will be discussing the science behind asbestos contamination and how it interacts with the medical, legal, and technical aspects of detecting and removing the contaminate. Webinar attendees will leave with a greater understanding of the motivation and reasoning behind current practices regarding asbestos.
Course topics include:
• The controversy surrounding the definition of asbestos as well as give the current operative definition delineated by NIOSH
• Identifying the major types of asbestos
• Major medical conditions resulting from asbestos exposure and current hypotheses regarding how pathologies develop
• Current federal regulations applying to asbestos, including recommended exposure limits
• Technologies for asbestos testing
• Future goals of NIOSH asbestos research and regulation
Register at: http://www.testamericainc.com/services/webinar_series.aspx
Dr. Manfrida will discuss USP <797> on August 2nd, 2012. This USP <797> training course provides information regarding the background and purpose of USP <797> and will discuss designing and executing a USP <797> sampling regimen.
USP <797> course topics include:
• History and background of USP <797>
• Where USP <797> regulation applies
• Determining what types of testing are needed
• Designing a testing regimen
• Interpreting data
• Investigation and remediation of contamination *****************Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Decon Labs, Inc. - Contamination Control Made Simpler
Decon Labs is the market leading manufacturer/supplier of disinfectants and cleaners made specifically for cleanrooms and compounding areas. Our wide range of sterile alcohol, sterile disinfectants, antimicrobial hand care products, pre-sat wipes, and cleaners will help you achieve USP 797 compliance. Our national distribution network makes our products readily available in local proximity to your compounding facilities. Decon’s trained staff will help you choose the proper product for your application making contamination control simple and easy.
Call us or visit our website to find out how we can help you. Toll Free 1-800-332-6647., www.deconlabs.com
Contact:
Mike Dunne
Decon Labs, Inc.
P 610.755.0800
F 610.270.8905
Mike Dunne
Decon Labs, Inc.
P 610.755.0800
F 610.270.8905
***************************Additional USP 797 news can be found on the USP
797 website www.usp797.org -
and the USP 797 blog http://www.usp797org.blogspot.com/ - and
the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Contec, Inc. Introduces QuicKlean™ Mop System with MicroGenesis™ Wipe
QuicKlean™ System makes ordering more convenient and economical.
Since its inception, the USP<797> market has struggled to find mopping systems to address their unique demands. Pharmacies have had to use products that are inadequate or considered excessive for use in their environments. The challenge that has been brought to our attention is to find ISO Class 7 cleanroom compatible materials that are not cost prohibitive and incorporate easy to use components. Pharmacies also need a system flexible enough to address all the USP<797> needs which include daily floor maintenance coupled with monthly ceiling and wall maintenance.
Contec worked with pharmacy technicians, buyers and directors to develop a system that meets all the USP<797> requirements. The result is the QuicKlean Mopping System. The new QuicKlean Mop System allows customers to use one part number for a smaller order of mop foam heads and covers - two bags of 50 MicroGenesis wipes, six foam mop heads. This is ideal for smaller pharmacies, labs and other critical areas where storage and space can be an issue. QuicKlean offers excellent performance, flexibility, convenience and affordability.
The QuicKlean™ Mop System is used with the latest microfiber wipe from Contec – the MicroGenesis™ wipe. MicroGenesis is a laundered microfiber wipe that is cut to 10” x 18” (25 x 46cm) so it can fit easily with the QuicKlean Mop System. Safe for use with most disinfectants, this system delivers the maximum amount of microfiber to pick-up and retain particles, dust, and other contaminants in cleanrooms and other critical applications.
For more information, please call 864-503-8333 or go to www.contecinc.com.
Contec worked with pharmacy technicians, buyers and directors to develop a system that meets all the USP<797> requirements. The result is the QuicKlean Mopping System. The new QuicKlean Mop System allows customers to use one part number for a smaller order of mop foam heads and covers - two bags of 50 MicroGenesis wipes, six foam mop heads. This is ideal for smaller pharmacies, labs and other critical areas where storage and space can be an issue. QuicKlean offers excellent performance, flexibility, convenience and affordability.
The QuicKlean™ Mop System is used with the latest microfiber wipe from Contec – the MicroGenesis™ wipe. MicroGenesis is a laundered microfiber wipe that is cut to 10” x 18” (25 x 46cm) so it can fit easily with the QuicKlean Mop System. Safe for use with most disinfectants, this system delivers the maximum amount of microfiber to pick-up and retain particles, dust, and other contaminants in cleanrooms and other critical applications.
For more information, please call 864-503-8333 or go to www.contecinc.com.
**************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Additional pharmacy design news can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Charlotte Safety & CleanroomSupplyConnection.com Expand USP797 Division
Charlotte Safety and CleanroomSupplyConnection.com have expanded their compounding pharmacy and cleanroom product offerings due to recent growth and need of their pharmacy clients. We are now an authorized dealer of SPS Medical sterilization products as well as Criti Clean cleanroom wipes and cleanroom clothing. Charlotte Safety is a master stocking distributor of all cleanroom supplies and products needed for the largest compounding pharmacies – both independent as well as hospital pharmacies. We offer special pricing on cleanroom mops,cleanroom disinfectants, cleanroom clothing, cleanroom presaturated wipes, tacky floor mats,cleanroom swabs and everything else you need to keep your cleanroom in top shape. We work with the country’s most well respected research and pharmaceutical facilities and offer expert advice on supplies, USP 797 protocol and streamlining your cleanroom supply inventory.
We also stock sterile cleanroom supplies including sterile cleanroom coveralls, sterile cleanroom sleeves, sterile face masks and sterile cleanroom paper.
Please visit us online at www.CleanroomSupplyConnection.com or call our toll free phone at 1-800-616-5319.
Contact:
Peter Lojac
Charlotte Safety & CleanroomSupplyConnection.com
P 516.596.8781
F 516.596.8619
E Sales@CleanroomSupplyConnection.com
***************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Monday, November 26, 2012
Pharmacy Design Featured on LinkedIn.com
About Pharmacy Design
Pharmacy Design at www.pharmacydesign.org
offers facility managers, pharmacy managers, pharmacy purchasing agents, and
pharmacy owners a comprehensive directory for all products and services needed
to design, build, equip, and manage a state-of-the-art pharmacy.
Pharmacy Design Services and Products found on the Pharmacy
Design website include: Pharmacy Architecture, Pharmacy Automation, Pharmacy
Consulting, Pharmacy Design, Pharmacy Construction, Pharmacy Planning, Pharmacy
Project Management, Pharmacy Products, Pharmacy Equipment, and Pharmacy
Software.
The site features a number of prominent pharmacy architects
including the well-known United States Pharmacy Architecture firm Bernstein
& Associates, Architects (http://www.bernarch.com/Healthcare-Pharmacy.htm),
and the well-known Italian Pharmacy Architecture firm Sartoretto Verna (http://www.sartorettoverna.com/pharmacy-design-malta.html).
The site also features numerous pharmacy design articles (http://pharmacydesign.org/Articles.html)
and pharmacy design vendors (http://pharmacydesign.org/Vendors.html).
Additional pharmacy design resources include the USP 797
website (www.usp797.org).
For more information on pharmacy design, contact:
Pharmacy Design
1201 Broadway - #803, New York, NY 10001
T: 212.463.0800
F: 888.214.0670
Thursday, October 25, 2012
USP 797 Seminar Announcement
USP 797 Compounding Pharmacy Compliance
Tuesday, November 13, 2012 9:00 AM - 11:00 AM PST
Webinar Registration
Technical Safety Services, Inc. (TSS) and EMLab P&K invite you to attend a complimentary webinar addressing USP 797 compliance issues on Tuesday, November 13, 2012 (9:00am-11:00am, Pacific; 12:00pm-2:00pm, Eastern). Please plan to join the webinar 15 minutes before the scheduled time.
Register online: https://www2.gotomeeting.com/register/499403946
You will gain a better understanding of the guidelines that make up USP 797, learn about the types of monitoring used to demonstrate USP 797 compliance, and discuss facility design and its implications on USP 797 compliance. Your instructors will be: Andrew King (TSS) and Dr. Joseph Manfrida (EMLab P&K).
Topics include:
• History and background of USP 797
• USP 797 regulation enforcement
• How to determine what types of testing are needed
• Designing and implementing a testing regimen
• Investigation and remediation of detected contamination
NOTE: TSS will provide certificates of attendance to attendees who complete the survey after the webinar.
About Andrew King (TSS)
Andrew King is the USP 797 Compliance and Engineering Specialist for Technical Safety Services, Inc., the largest cleanroom testing and certification company in the U.S. Andrew is credentialed as a Registered Cleanroom Certification Professional in Sterile Compounding (RCCP-SC) through the industry association CETA. He maintains TSS’ SOPs to ensure ongoing compliance with USP 797 standards, and leads the development of TSS’ training program for testing/certification at sterile compounding facilities.
About Joseph Manfrida, Ph.D. (EMLab P&K)
Dr. Joseph Manfrida is a consultant in the microbiology field. Dr. Manfrida was instrumental in establishing EMLab P&K's USP 797 services and was trained at the Baxa STAR Center by experts from the United States Pharmacopeia (USP) Sterile Compounding Committee. He holds a B.S. in Biology from the University of Texas and a Ph.D. in Microbiology from Arizona State University.
We hope you can join us for this complimentary webinar: https://www2.gotomeeting.com/register/499403946
Topics include:
• History and background of USP 797
• USP 797 regulation enforcement
• How to determine what types of testing are needed
• Designing and implementing a testing regimen
• Investigation and remediation of detected contamination
NOTE: TSS will provide certificates of attendance to attendees who complete the survey after the webinar.
About Andrew King (TSS)
Andrew King is the USP 797 Compliance and Engineering Specialist for Technical Safety Services, Inc., the largest cleanroom testing and certification company in the U.S. Andrew is credentialed as a Registered Cleanroom Certification Professional in Sterile Compounding (RCCP-SC) through the industry association CETA. He maintains TSS’ SOPs to ensure ongoing compliance with USP 797 standards, and leads the development of TSS’ training program for testing/certification at sterile compounding facilities.
About Joseph Manfrida, Ph.D. (EMLab P&K)
Dr. Joseph Manfrida is a consultant in the microbiology field. Dr. Manfrida was instrumental in establishing EMLab P&K's USP 797 services and was trained at the Baxa STAR Center by experts from the United States Pharmacopeia (USP) Sterile Compounding Committee. He holds a B.S. in Biology from the University of Texas and a Ph.D. in Microbiology from Arizona State University.
We hope you can join us for this complimentary webinar: https://www2.gotomeeting.com/register/499403946
USP <797> Compliance Webinar
Tuesday, November 13, 2012
9:00 am - 11:00 am (Pacific)
12:00 pm - 2:00 pm (Eastern)
Sponsored by EMLab P&K and Technical Safety Services, Inc. (TSS)
If you have questions or need assistance, please email us or call our webinar support line toll-free at (855) 888-6094.
We hope you can join us!
Please contact us for additional information:
Technical Safety Services, Inc. [TSS]620 Hearst Ave.Berkeley, CA 94710800.877.7742www.techsafety.cominfo@techsafety.com
Subscribe to:
Posts (Atom)